Moderna Recursion: Which Cutting-Edge Path Is Best in 2026
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
An overview of where to locate stock index listings worldwide, with guidance on finding the right benchmarks for your analysis.
17,106 articlesTwo biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
As AI expands, data-center construction flourishes. This piece explains why sterling infrastructure should regain mom...
SK Hynix kicked off trading on Wall Street with a double-digit rally, marking the largest U.S. IPO by a foreign compa...
As Verizon nears its July 24 earnings, investors are eyeing a potential near-25% upside driven by steady cash flow, a...
SK Hynix shares rebound 8% amid bargain-hunting after HSBC reaffirmed SKHY as a top chip pick. The move comes as inve...
Direxion has unveiled SKHL, a 2X leveraged ETF tied to SK hynix, signaling a new foray into the memory-chip space. Th...
Navigate Neptune's Q4 2025 performance, understand margin dynamics, and gauge 2026 guidance. This practical guide exp...
Dominion Energy 2025 earnings shaped the 2026 outlook. This analysis breaks down the Q4 results, key drivers, and wha...
In 2025, rare earths drew intense attention as prices and equities raced higher. The rally cooled quickly, leaving in...
Bastion Asset Management just revealed a new stake in Parsons, signaling confidence in steady government spending on ...
As energy markets tilt between supply concerns and resilient cash flow, March can be a strategic moment to position f...
Costco is set to report Q2 FY2026 results after the bell, with analysts projecting a solid beat on earnings and reven...